Concepedia

Prognostic Staging Systems

Prognostic Staging Systems is a clinical framework that categorizes the progression and expected clinical outcome of Multiple Myeloma by integrating disease-specific biomarkers and patient characteristics to stratify risk and guide therapeutic decisions.

585

Publications

62K

Citations

4.1K

Authors

1.4K

Institutions

Publications per year

2017–2026

196

Parents

Publications

585

International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

Peter L. Greenberg, Christopher Cox, Michelle M. LeBeau et al. · Blood · 1997 · 4.5K citations · Full text

, , +13

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Peter L. Greenberg, Heinz Tuechler, Julie Schanz et al. · Blood · 2012 · 3.1K citations · Full text

, , +12

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

Brian G.M. Durie, Sydney E. Salmon · Cancer · 1975 · 3.1K citations

, , +15

International Staging System for Multiple Myeloma

Philip R. Greipp, Jesús F. San Miguel, Brian G.M. Durie et al. · Journal of Clinical Oncology · 2005 · 2.9K citations

, , +14

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

Antonio Palumbo, Hervé Avet‐Loiseau, Stefania Oliva et al. · Journal of Clinical Oncology · 2015 · 2.2K citations · Full text

, , +16

1–5 of 585

Authors

4.1K

  1. JF
    Jesús F. San Miguel

    Universidad de Salamanca, Spain

    20 publications · 8.8K citations

    18

    h-index

  2. RA
    Robert A. Kyle

    Mayo Clinic, United States

    20 publications · 7.1K citations

    18

    h-index

  3. BG
    Brian G.M. Durie

    Cedars-Sinai Medical Center, United States

    18 publications · 11.4K citations

    17

    h-index

  4. SV
    S. Vincent Rajkumar

    Mayo Clinic in Arizona, United States

    17 publications · 6.1K citations

    16

    h-index

  5. MΑ
    Meletios Α. Dimopoulos

    National and Kapodistrian University of Athens, Greece

    18 publications · 4.8K citations

    16

    h-index

1–5 of 4.1K

Institutions

1.4K

  1. Mayo Clinic in Arizona

    Scottsdale, United States

    26 h-index

    221 publications

    37.1K citations

  2. Mayo Clinic

    Rochester, United States

    24 h-index

    155 publications

    39.4K citations

  3. Istituti di Ricovero e Cura a Carattere Scientifico

    Rome, Italy

    22 h-index

    126 publications

    30.7K citations

  4. The University of Texas MD Anderson Cancer Center

    Houston, United States

    21 h-index

    103 publications

    19.8K citations

  5. University of Pavia

    Pavia, Italy

    17 h-index

    63 publications

    14.4K citations

  6. National and Kapodistrian University of Athens

    Athens, Greece

    17 h-index

    104 publications

    8.5K citations

  7. Heinrich Heine University Düsseldorf

    Düsseldorf, Germany

    16 h-index

    85 publications

    78.4K citations

  8. Dana-Farber Cancer Institute

    Boston, United States

    15 h-index

    33 publications

    5.7K citations

1–8 of 1.4K

Venues

  1. Blood

    46 publications · 15.8K citations

    34

    h-index

  2. British Journal of Haematology

    BJH · 37 publications · 2.9K citations

    27

    h-index

  3. Journal of Clinical Oncology

    25 publications · 11.1K citations

    22

    h-index

  4. Cancer

    28 publications · 6.9K citations

    21

    h-index

  5. Leukemia

    20 publications · 2.3K citations

    20

    h-index

1–5